<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药融圈 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-02T11:20:11+08:00</updated>
  <subtitle>药融圈PHARNEX汇聚数万医药大咖，得到数千家医药创业者鼎力支持，开展日常专题讲座。致力于成为“专业、前沿、权威、严谨”的医药行业资讯平台，以及项目、技术、工厂、融资、股权投资等资源整合平台。欢迎您关注药融圈，共同碰撞“药”的火花!</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>大盘点：中国对海外药企，新药授权初露端倪</title>
    <updated>2020-12-01T17:27:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/0BajPg1--RHJyppruKrn1w</id>
    <link href="https://mp.weixin.qq.com/s/0BajPg1--RHJyppruKrn1w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>铿锵玫瑰--四川协力制药颜值才华兼具的新生代掌门人张弘</title>
    <updated>2020-12-01T17:27:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/e0Bk0rIBB8FiWXDe-8f09w</id>
    <link href="https://mp.weixin.qq.com/s/e0Bk0rIBB8FiWXDe-8f09w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肿瘤免疫药效评价适合选用哪些模型？</title>
    <updated>2020-12-01T17:27:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/DgbGcMURjj-39L3wUKZmpQ</id>
    <link href="https://mp.weixin.qq.com/s/DgbGcMURjj-39L3wUKZmpQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>糖尿病龙头—华东医药进入收获季，两款产品相继获批</title>
    <updated>2020-12-01T17:27:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/dQ12JqwezoIo8PVEUw2r0Q</id>
    <link href="https://mp.weixin.qq.com/s/dQ12JqwezoIo8PVEUw2r0Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“开挂”的博瑞医药——高壁垒原料药+制剂一体化平台</title>
    <updated>2020-12-01T17:27:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/MKG_xhJQHInnzJF6MIA89g</id>
    <link href="https://mp.weixin.qq.com/s/MKG_xhJQHInnzJF6MIA89g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【每日药闻】康泰生物子公司收到13价肺炎球菌结合疫苗注册现场检查通知...</title>
    <updated>2020-12-01T17:27:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/iNW9jCI_624XJAs5YMi7-Q</id>
    <link href="https://mp.weixin.qq.com/s/iNW9jCI_624XJAs5YMi7-Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【尾货处理】12月第1周优势尾货产品出炉，欢迎抢购！</title>
    <updated>2020-12-01T17:27:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/kWvDsCYvhruzEvSO5cmFwQ</id>
    <link href="https://mp.weixin.qq.com/s/kWvDsCYvhruzEvSO5cmFwQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药人的圣诞盛宴！行业大咖与您共聚石家庄免费制剂技术会议</title>
    <updated>2020-12-01T17:27:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/JZKGoK0NYgi45esY_eAz1w</id>
    <link href="https://mp.weixin.qq.com/s/JZKGoK0NYgi45esY_eAz1w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>欧康维视OT-401启动真实世界研究，这款首创新药有望加速上市</title>
    <updated>2020-11-30T19:05:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/75p9j49yx7FAy-3teG6RiA</id>
    <link href="https://mp.weixin.qq.com/s/75p9j49yx7FAy-3teG6RiA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肝癌大药：索拉非尼国内多家获批，未来或竞争激烈</title>
    <updated>2020-11-30T19:05:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/SUoz8PCXquDqWdF2iSgpOQ</id>
    <link href="https://mp.weixin.qq.com/s/SUoz8PCXquDqWdF2iSgpOQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【每日药闻】德琪医药：附属德琪浙江收到一笔2678.1万元的政府奖励...</title>
    <updated>2020-11-30T19:05:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/EUx3ufuu9BcpXN0XNmk-1Q</id>
    <link href="https://mp.weixin.qq.com/s/EUx3ufuu9BcpXN0XNmk-1Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亚盛医药获得基于PROTAC技术的MDM2蛋白降解剂的独家许可</title>
    <updated>2020-11-30T19:05:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/cYloKFyFP5C2PMKHoVqSjw</id>
    <link href="https://mp.weixin.qq.com/s/cYloKFyFP5C2PMKHoVqSjw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药人的圣诞盛宴！行业大咖与您共聚石家庄免费制剂技术会议</title>
    <updated>2020-11-30T19:05:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/978q0pCJteZB6qZdAm3C2A</id>
    <link href="https://mp.weixin.qq.com/s/978q0pCJteZB6qZdAm3C2A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>为什么这款改良新药可以获批？有什么看点？</title>
    <updated>2020-11-30T19:05:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/qGc86G5DhvGv6EgbjiBZOg</id>
    <link href="https://mp.weixin.qq.com/s/qGc86G5DhvGv6EgbjiBZOg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>溶瘤病毒治疗挑战与进展</title>
    <updated>2020-11-30T19:05:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/QYYp0WOyQRkTjtC1lQ3Axg</id>
    <link href="https://mp.weixin.qq.com/s/QYYp0WOyQRkTjtC1lQ3Axg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞医药子公司—成都盛迪医药获得药品注册批件</title>
    <updated>2020-11-30T19:05:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/Kq9ufvA452biNvKUyT-x7w</id>
    <link href="https://mp.weixin.qq.com/s/Kq9ufvA452biNvKUyT-x7w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>石药集团业绩持续上涨；在研新药管线丰富</title>
    <updated>2020-11-29T20:32:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/_xtIa8ysgbvTFILzmFqcOw</id>
    <link href="https://mp.weixin.qq.com/s/_xtIa8ysgbvTFILzmFqcOw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一文概览，国际中等特色专科药企业：丽珠集团</title>
    <updated>2020-11-29T20:32:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/Yz9jZatGR9iJlVQdeN0pxg</id>
    <link href="https://mp.weixin.qq.com/s/Yz9jZatGR9iJlVQdeN0pxg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【每日药闻】艾伯维(ABBV.US)宣布Humira用于治疗新适应症获批...</title>
    <updated>2020-11-29T20:32:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/jAbiNxd1b3z388LyyYEExA</id>
    <link href="https://mp.weixin.qq.com/s/jAbiNxd1b3z388LyyYEExA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>晖致正式成立，致力于满足全球不断变化的医疗需求</title>
    <updated>2020-11-29T20:32:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/m_TB0V0UqyD7CbQ5v_M6rA</id>
    <link href="https://mp.weixin.qq.com/s/m_TB0V0UqyD7CbQ5v_M6rA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>